{"disease":{"id":"chronic-atrial-fibrillation","name":"chronic atrial fibrillation"},"drugs":{"marketed":[{"drug_id":"dabigatran","indication_name":"Prevention of Thromboembolism with Chronic Atrial Fibrillation","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Pradaxa","generic_name":"dabigatran etexilate","company_name":"Generic (originally Boehringer Ingelheim)","drug_phase":"marketed","molecular_target":"Multidrug and toxin extrusion protein 1, Multidrug and toxin extrusion protein 2, Ribosyldihydronicotinamide dehydrogenase [quinone]","drug_class":"Direct oral anticoagulant (DOAC) — direct thrombin inhibitor","quality_score":69,"revenue":"1200","mechanism":"Direct thrombin inhibitor that blocks both free and clot-bound thrombin, providing anticoagulation without routine monitoring."},{"drug_id":"dabigatran-etexilate-de","indication_name":"Prevention of Thromboembolism with Chronic Atrial Fibrillation","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Dabigatran etexilate (DE)","generic_name":"dabigatran-etexilate-de","company_name":"Pfizer Inc.","drug_phase":"discontinued","molecular_target":"Multidrug and toxin extrusion protein 1, Multidrug and toxin extrusion protein 2, Ribosyldihydronicotinamide dehydrogenase [quinone]","drug_class":"Dabigatran etexilate (DE) as oral capsule","quality_score":null,"revenue":null,"mechanism":"Dabigatran etexilate (DE) as oral capsule"},{"drug_id":"dabigatran-etexilate","indication_name":"Prevention of Thromboembolism with Chronic Atrial Fibrillation","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Pradaxa","generic_name":"dabigatran-etexilate","company_name":"Boehringer Ingelheim","drug_phase":"marketed","molecular_target":"Thrombin (serine protease)","drug_class":"Direct thrombin inhibitor","quality_score":71,"revenue":null,"mechanism":"Competitive direct thrombin inhibitor preventing fibrin formation and thrombus development."},{"drug_id":"verapamil-hydrochloride","indication_name":"Control of ventricular rate at rest in patients with chronic atrial flutter and/or atrial fibrillation (in association with digitalis)","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Verapamil Hydrochloride","company_name":"Pfizer Inc.","drug_phase":"marketed","molecular_target":"L-type calcium channels (slow channels)","drug_class":"Calcium channel blocker","quality_score":56,"revenue":null,"mechanism":"Calcium ion influx inhibitor that modulates ionic calcium across cell membranes of arterial smooth muscle and myocardial cells."},{"drug_id":"verapamil-hydrochloride","indication_name":"Control of ventricular rate during stress in patients with chronic atrial flutter and/or atrial fibrillation (in association with digitalis)","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Verapamil Hydrochloride","company_name":"Pfizer Inc.","drug_phase":"marketed","molecular_target":"L-type calcium channels (slow channels)","drug_class":"Calcium channel blocker","quality_score":56,"revenue":null,"mechanism":"Calcium ion influx inhibitor that modulates ionic calcium across cell membranes of arterial smooth muscle and myocardial cells."},{"drug_id":"warfarin","indication_name":"Prevention of Thromboembolism with Chronic Atrial Fibrillation","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Coumadin","generic_name":"warfarin","company_name":"Generic (originally Wisconsin Alumni Research Foundation)","drug_phase":"marketed","molecular_target":"Vitamin K epoxide reductase complex subunit 1-like protein 1, Cytochrome P450 2C9, Proprotein convertase subtilisin/kexin type 7","drug_class":"Vitamin K antagonist (anticoagulant)","quality_score":60,"revenue":null,"mechanism":"Inhibits vitamin K epoxide reductase, blocking the synthesis of vitamin K-dependent clotting factors (II, VII, IX, X) to prevent thrombosis."}],"pipeline":[],"offLabel":[],"totalMarketed":6,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT05690009","title":"Real Clinical Practice Register of AlbUminuRia Detection in Patients With Previously undiAgnosed Chronic Kidney Disease","phase":"","overall_status":"COMPLETED","enrollment_count":4580,"lead_sponsor_name":"Eurasian Association of Therapists","has_results":false},{"nct_id":"NCT05226416","title":"Analysis of Health Status of Сomorbid Adult Patients With COVID-19 Hospitalised in Fourth Wave of SARS-CoV-2 Infection","phase":"","overall_status":"COMPLETED","enrollment_count":3554,"lead_sponsor_name":"Eurasian Association of Therapists","has_results":false},{"nct_id":"NCT05679024","title":"Stroke Prophylaxis With Apixaban in Chronic Kidney Disease Stage 5 Patients With Atrial Fibrillation","phase":"PHASE3","overall_status":"RECRUITING","enrollment_count":1400,"lead_sponsor_name":"Region Stockholm","has_results":false},{"nct_id":"NCT03451630","title":"Integrated Care (IC) Models for Patient-Centered Outcomes","phase":"NA","overall_status":"COMPLETED","enrollment_count":1400,"lead_sponsor_name":"University of Pittsburgh","has_results":true},{"nct_id":"NCT05852704","title":"SGLT2 Inhibitor TrEatment iN Patients Awaiting cOronary arTery bYpass Surgery to Reduce Post-opErative AF","phase":"PHASE3","overall_status":"RECRUITING","enrollment_count":800,"lead_sponsor_name":"Region Örebro County","has_results":false},{"nct_id":"NCT05045742","title":"Prediction of Patient Deterioration Using Machine Learning","phase":"","overall_status":"COMPLETED","enrollment_count":526,"lead_sponsor_name":"Brigham and Women's Hospital","has_results":false},{"nct_id":"NCT04849312","title":"Prediction of 30-Day Readmission Using Machine Learning","phase":"","overall_status":"COMPLETED","enrollment_count":372,"lead_sponsor_name":"Brigham and Women's Hospital","has_results":false},{"nct_id":"NCT04542785","title":"Lenient Rate Control Versus Strict Rate Control for Atrial Fibrillation. The Danish Atrial Fibrillation Randomised Clinical Trial","phase":"NA","overall_status":"UNKNOWN","enrollment_count":350,"lead_sponsor_name":"Holbaek Sygehus","has_results":false},{"nct_id":"NCT06291506","title":"SUbstrate Ablation in Persistent Atrial Fibrillation for Elimination of Recurrences (SUPAFER).","phase":"NA","overall_status":"RECRUITING","enrollment_count":176,"lead_sponsor_name":"Hospital Universitario La Paz","has_results":false},{"nct_id":"NCT04080570","title":"Remote Physician Care for Home Hospital Patients","phase":"NA","overall_status":"COMPLETED","enrollment_count":172,"lead_sponsor_name":"Brigham and Women's Hospital","has_results":false},{"nct_id":"NCT07152301","title":"Inflammation, Epigenetics in CHF Patients With AF","phase":"","overall_status":"COMPLETED","enrollment_count":164,"lead_sponsor_name":"University of Palermo","has_results":false},{"nct_id":"NCT05256303","title":"Rural Hospital-Level Care at Home for Acutely Ill Adults","phase":"NA","overall_status":"COMPLETED","enrollment_count":160,"lead_sponsor_name":"Brigham and Women's Hospital","has_results":false},{"nct_id":"NCT03057548","title":"Comparison of Pulmonary Vein Ablation With or Without Left Atrial Posterior Wall Ablation for Persistent AF (PIVoTAL)","phase":"NA","overall_status":"COMPLETED","enrollment_count":110,"lead_sponsor_name":"Arash Aryana, MD","has_results":true},{"nct_id":"NCT02202967","title":"Misoprostol for Small Bowel Ulcers and Obscure Bleeding Due to Aspirin or Nonsteroidal Antiinflammatory Drugs","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":104,"lead_sponsor_name":"NHS Greater Glasgow and Clyde","has_results":false},{"nct_id":"NCT03295422","title":"Comparison of Two Pulmonary Vein Ablation Techniques for Persistent AF","phase":"NA","overall_status":"UNKNOWN","enrollment_count":100,"lead_sponsor_name":"Sequoia Hospital","has_results":false},{"nct_id":"NCT03203759","title":"Hospital-Level Care at Home for Acutely Ill Adults","phase":"NA","overall_status":"COMPLETED","enrollment_count":91,"lead_sponsor_name":"Brigham and Women's Hospital","has_results":false},{"nct_id":"NCT05393180","title":"CONVERGE Post-Approval Study (PAS)","phase":"NA","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":53,"lead_sponsor_name":"AtriCure, Inc.","has_results":false},{"nct_id":"NCT07257614","title":"Left Atrial Appendage Occlusion in Dialysis Patients With Atrial Fibrillation: A Multicentre Pilot Study","phase":"","overall_status":"NOT_YET_RECRUITING","enrollment_count":40,"lead_sponsor_name":"Prince of Wales Hospital, Shatin, Hong Kong","has_results":false},{"nct_id":"NCT04531280","title":"Rural Home Hospital: Proof of Concept","phase":"NA","overall_status":"COMPLETED","enrollment_count":7,"lead_sponsor_name":"Brigham and Women's Hospital","has_results":true},{"nct_id":"NCT07493798","title":"Serum Potassium Prediction Using Machine Learning and Single-lead ECG","phase":"","overall_status":"WITHDRAWN","enrollment_count":0,"lead_sponsor_name":"Brigham and Women's Hospital","has_results":false},{"nct_id":"NCT04784351","title":"Prediction of Expected Length of Hospital Stay Using Machine Learning","phase":"","overall_status":"WITHDRAWN","enrollment_count":0,"lead_sponsor_name":"Brigham and Women's Hospital","has_results":false}],"total":21},"guidelines":[],"source":"Drug Landscape verified database"}